<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medinfo</journal-id><journal-title-group><journal-title xml:lang="ru">Актуальные проблемы теоретической и клинической медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Actual Problems of Theoretical and Clinical Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2790-1289</issn><issn pub-type="epub">2790-1297</issn><publisher><publisher-name>Казахстанско-Российский медицинский университет</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24412/2790-1289-2021-1137140</article-id><article-id custom-type="elpub" pub-id-type="custom">medinfo-107</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЙ СЛУЧАЙ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL CASE</subject></subj-group></article-categories><title-group><article-title>ОСОБЕННОСТИ ТЕЧЕНИЯ COVID-19 У ПОЛИМОРБИДНОГО ПОЖИЛОГО ПАЦИЕНТА</article-title><trans-title-group xml:lang="en"><trans-title>FEATURES OF THE COURSE OF COVID-19 IN A POLYMORBID ELDERLY PATIENT</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зординова</surname><given-names>К. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Zordinova</surname><given-names>K. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жангабылов</surname><given-names>А. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhangabylov</surname><given-names>A. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор</p></bio><bio xml:lang="en"><p>MD, Professor</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гуламова</surname><given-names>Г. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Gulamova</surname><given-names>G. M.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">НУО «Казахстанско-Российский медицинский университет»<country>Казахстан</country></aff><aff xml:lang="en">NEI «Kazakh-Russian Medical University»<country>Kazakhstan</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">НАО «КазНМУ имени С.Д. Асфендиярова»<country>Казахстан</country></aff><aff xml:lang="en">NC JSC «KazNMU named S.D. Asfendiyarov»<country>Kazakhstan</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>27</day><month>10</month><year>2022</year></pub-date><volume>0</volume><issue>1</issue><fpage>137</fpage><lpage>140</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Зординова К.А., Жангабылов А.К., Гуламова Г.М., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Зординова К.А., Жангабылов А.К., Гуламова Г.М.</copyright-holder><copyright-holder xml:lang="en">Zordinova K.A., Zhangabylov A.K., Gulamova G.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://kazrosmedjournal.krmu.edu.kz/jour/article/view/107">https://kazrosmedjournal.krmu.edu.kz/jour/article/view/107</self-uri><abstract><p>Проблема коронавирусной инфекции в 2020 году охватила весь мир, распространилась в виде пандемии и разразилась с молниеносной скоростью. Не осталось ни одного уголка земли, куда бы ни дошел вирус и не сделал бы свое «черное» дело. Высокая контагиозность, отсюда и высокая заболеваемость, смертность на первых порах, поразившая весь мир и все медицинское сообщество. В первое время врачи не знали, как лечить, что предпринять? В здравоох- ранении практически всех стран наступил период паники, срочно вводились карантинные мероприятия в надежде, что за это время можно было что-либо предпринять или организовать. И Казахстан не был исключением. Печальная статистика такова: на 31.01.2021 года заразились 103 миллиона 213 тысяч 392 человека. 2 миллиона 231 тысяча 154 c летальным исходом. Уровень смертности составил 2,16% [<xref ref-type="bibr" rid="cit1">1</xref>]. В данной статье предлагаем клинический случай ведения пожилой пациентки с достоверным диагнозом COVID-19 на фоне полиморбидной соматической патологии.</p></abstract><trans-abstract xml:lang="en"><p>The problem of coronavirus infection in 2020 swept the entire world at lightning speed. This is due to the fact that the pandemic has broken out across the globe. There is not a single corner of the earth where the virus has not reached and has not done its "dirty" deed. High contagiousness, hence the high morbidity and mortality at first amazed the whole world, the entire medical community. The doctors did not know how to treat, what to do. In the health care of almost all countries, a period of panic began, urgent quarantine measures were introduced in the hope of having time to organize something during this time. Kazakhstan is no exception. The sad statistics are as follows: as of January 31, 2021, 103 million 213 thousand 392 people were infected, 2 million 231 thousand 154 people have died. The mortality rate was 2.16%. In your opinion, we offer a clinical case of an elderly patient with a reliably confirmed diagnosis of Covid-19 against the background of polymorbid somatic pathology.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>коронавирусная инфекция</kwd><kwd>пневмония</kwd><kwd>полиморбидность</kwd><kwd>пожилой возраст</kwd></kwd-group><kwd-group xml:lang="en"><kwd>coronavirus infection</kwd><kwd>pneumonia</kwd><kwd>polymorbidity</kwd><kwd>old age</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">ВОЗ. 2021 г. Январь. Сведения о КВИ.</mixed-citation><mixed-citation xml:lang="en">ВОЗ. 2021 г. Январь. Сведения о КВИ.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Grasselli G., Zangrillo A., Zanella A., et al; COVID-19 Lombardy ICU Network. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020 Published online April 6, 2020. doi:10.1001/jama.2020.5394.</mixed-citation><mixed-citation xml:lang="en">Grasselli G., Zangrillo A., Zanella A., et al; COVID-19 Lombardy ICU Network. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020 Published online April 6, 2020. doi:10.1001/jama.2020.5394.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Романов Б.К. Коронавирусная инфекция Ковид – 2019. Безопасность и риск армакотерапии 2020; 8 (1): 3-8.</mixed-citation><mixed-citation xml:lang="en">Романов Б.К. Коронавирусная инфекция Ковид – 2019. Безопасность и риск армакотерапии 2020; 8 (1): 3-8.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Gu J., Han B., Jian Wang J. COVID-19: Gastrointestinal manifestations and potential fecaloral transmission. Gastroenterology. 2020. https://doi.org/10.1053/j.gastro.2020.02.054.</mixed-citation><mixed-citation xml:lang="en">Gu J., Han B., Jian Wang J. COVID-19: Gastrointestinal manifestations and potential fecaloral transmission. Gastroenterology. 2020. https://doi.org/10.1053/j.gastro.2020.02.054.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Paz Ocaranza M., Riquelme J.A., García L., et al. Counterregulatory reninangiotensin system in cardiovascular disease. Nat Rev Cardiol. 2020;17 (2):116 - 129. doi:10.1038/s41569-019-0244-8.</mixed-citation><mixed-citation xml:lang="en">Paz Ocaranza M., Riquelme J.A., García L., et al. Counterregulatory reninangiotensin system in cardiovascular disease. Nat Rev Cardiol. 2020;17 (2):116 - 129. doi:10.1038/s41569-019-0244-8.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou F., Yu T., Du R., et al. Clinical course and risk factors for mortality of adult inpatients ith COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395 (10229):1054-1062. doi:10.1016/S0140-6736 (20) 30566-3.</mixed-citation><mixed-citation xml:lang="en">Zhou F., Yu T., Du R., et al. Clinical course and risk factors for mortality of adult inpatients ith COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395 (10229):1054-1062. doi:10.1016/S0140-6736 (20) 30566-3.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Arentz M., Yim E., Klaff L., et al. Characteristics and outcomes of 21 critically illpatients ith COVID - 19 in Washington State. JAMA. 2020 Published online March 19, 2020 doi:10.1001/jama.2020.4326.</mixed-citation><mixed-citation xml:lang="en">Arentz M., Yim E., Klaff L., et al. Characteristics and outcomes of 21 critically illpatients ith COVID - 19 in Washington State. JAMA. 2020 Published online March 19, 2020 doi:10.1001/jama.2020.4326.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang L., Liu Y. Potential interventions for novel coronavirus in China: A systematic review. J. Med Virol. 2020; 92 (5):479 - 490. doi:10.1002/jmv.25707.</mixed-citation><mixed-citation xml:lang="en">Zhang L., Liu Y. Potential interventions for novel coronavirus in China: A systematic review. J. Med Virol. 2020; 92 (5):479 - 490. doi:10.1002/jmv.25707.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
